IQVIA's 42% Run Isn't Done — Sell the Dip You Don't Expect
IQVIA just won an AI Breakthrough Award, got crowned the No. 1 pharma tech provider by Everest Group, and its stock is up 42% in three months. So naturally, we're selling a put $10 below the current p
Atlas Portfolio results referenced in this post are produced in a simulation environment using EOD market data and contract pricing. They are not records of trades placed in a brokerage account or executed with real capital, and individual results would vary based on fills, commissions, slippage, and account size. Tiblio is a software platform for finding and executing options trade ideas. We are not a registered investment advisor or broker-dealer. Nothing in this post is financial advice. Options trading involves substantial risk of loss. Past or simulated performance does not guarantee future results.